Multiplexed Lateral Flow Assay Development: Benefits, Risks, and Strategies for Success in Infectious Diseases and Oncology

Lateral flow assay applications have become increasingly diverse in a post-pandemic world, and the areas of infectious disease and oncology continue to be at the forefront. In both areas, the use of multiplexing to meet market demands or resolve technical limitations has become more commonplace. However, multiplexing is not without its risks. Determining whether multiplexing is the correct path for your product and being able to predict potential pitfalls in development will both be essential to project success. In this webinar we will review the benefits and risks of multiplexing, discuss various development strategies, and examine common obstacles as they pertain to assays in the infectious diseases and oncology space.

 

Learning Objectives